It's as simple as this. Pharma is financially bankrupt - they need a blockbuster drug for a blockbuster pandemic. https://endpts.com/pharmas-broken-business-model-an-industry-on-the-brink-of-terminal-decline/

permalink

This is a LONG article. I only posted the introduction and the ivermectin section. Chrome's English translation is weird in spots.

France is much more aggressive about preventing off-label use than the US, it seems.

However, this was posted on 2020-11-22. Is FaceBook banning ivermectin?

In September 2020, Dr. Lee Merritt (former president of the Association of American Physicians and Surgeons) throws a stone in the pond: what if the truth had been suppressed for more than 40 years? Is the vaccine the only solution for certain viruses such as SARS-CoV-2? This Covid-19 crisis points to other medical dogmas such as therapeutic indications and off-label prescriptions. To what extent can we temporarily unblock the use of an already known drug in an epidemic emergency? From a methodological point of view, we now only hear about randomized trials. Observational and clinical medicine, which has made it possible to develop the vast majority of existing therapies, no longer has a say in the matter. Thus, through the cabal against hydroxychloroquine, it is all the early therapeutic management of the Covid-19 epidemic that has been strangled. Purposely ? Mainstream media seem to bear their share of the blame. Around the world, proposals for early outpatient treatment of the epidemic are increasing. Many combination therapies appear to rely on antibiotics such as azithromycin or doxycycline. Would they be the centerpieces against Covid-19? Would the idea of ​​effective antibiotics against a virus therefore be sacrilegious at this point? France, constrained, seems to have been the territory of many therapeutic proposals involving antibiotics. However, city medicine found itself in a difficult position: prohibition of prescribing, out of stock of drugs, summons to the council of the order, recommendations going against the use of antibiotics, missing information… Groups such as “Let the doctors prescribe” and “Azithro for hospitalization” are working for the truth. Chemoprevention also seems to be completely obscured. Is the vaccine the only solution? How to get out of the deadlock when we do not encourage early curative care or chemoprophylaxis which have been on the table for months?

In Australia, Professor Thomas Borody is advocating for doxycycline / ivermectin / zinc triple therapy against the coronavirus epidemic [6] [7] [20]. He specifies that Australian doctors could very well legally prescribe this triple therapy “off label” (in France it looks like off-label) [21].

Globally, early treatment in ambulatory medicine is becoming more refined.

From March 2020, Didier Raoult offered a dual azithromycin / hydroxychloroquine therapy. Since zinc has complemented this approach [7].

From March also, the American doctor Zelenko offers triple therapy azithromycin / hydroxychloroquine / zinc. He has since proposed doxycycline as an alternative to azithromycin [7].

In Australia, Professor Thomas Borody is said to have declared that Covid-19 is “treatable” and “easier to treat than the flu” [6] [58]. This Australian researcher has been offering doxycycline / ivermectin / zinc triple therapy since August 2020 [6] [59] [60].

In Peru, Doctor Gustavo Aguirre Chang has been on the therapeutic path to ivermectin for months [6] [61]. He now proposes to combine this compound with doxycycline or azithromycin for early management [6] [62] [63]. It also combines bromhexine [6] [62] [63]. Its therapeutic proposal gives indications for all phases of the disease: prophylaxis, mild phase, moderate, severe and critical. There are also, depending on the severity, anticoagulants, anti-inflammatories, antibiotics from the third generation cephalosporin (C3G) family. . .

A recent review, published in August 2020 in The American Journal of Medicine [7] [64], proposes a complete outline of stratified outpatient management. This early treatment was completed in October and is available on the website of the Association of American Physicians and Surgeons [65] [66] [67] [68] [69] [70]. This algorithm involves first zinc, then the combination of an antibiotic ( azithromycin or doxycycline ) with hydroxychloroquine or ivermectin orfavipiravir. If necessary, this treatment can be supplemented on an outpatient basis with an anti-inflammatory and then an anticoagulant.

In Florida, the ICAM protocol was developed. It combines vitamin C, zinc, a corticosteroid, an anticoagulant and a macrolide [70b] [70c].

The ivermectin is a medicament which one speaks increasingly against the Covid-19 [71] [72] [73] [73b]. In France, Doctor Gérard Maudrux presented this testimony in June 2020: “My attention is drawn by Australian and American publications on the effect of Ivermectin, which I know well for having treated two epidemics of scabies in retirement homes and in a training center in 2019, successfully and without side effects. I start prescribing as a single dose on April 6th. Satisfied with the results, so I continue: 27 patients. The 48 hour results are astounding with disappearance of clinical signs for all. Too happy to share these results thinking I am helping I talk about it, which earned me severe reproaches from colleagues and a pharmacist. With the warning of the Order, I resigned myself to fit into the mold and prescribed Doliprane. " [74]. The Montpellier biotech MedinCell seems to be interested in ivermectin. However, its investigations do not seem to be carried out to quickly offer a short-term curative treatment for Covid-19, but to develop a new preventive drug… in the future [75]. Policy of profit and not of care? Today it is a question of a petition in court by lawyer Jean-Charles Teissèdre “on behalf of the association Victimes coronavirus France” concerning the temporary use of ivermectin in the fight against this coronavirus [75b] [75c].

Medincell's trial is underway, finally.

The favipiravir is an antiviral approved in Japan [76]. It seems to have been tested against Covid-19 with rather honorable effectiveness in Japan [77], India, China and Russia [78] [79] [80] [81].

The bromhexine appears to have given the first interesting results in the Middle East [82] [83] [84] [85]. Its curative potential is discussed, as is that of ambroxol [86], a similar active ingredient [87] [88] [89]. The possibility of SARS-CoV-2 being able to enter cells according to several entry patterns is mentioned. Hydroxychloroquine could act on an entry pattern that is not the main route of infection. While bromhexine and ambroxol could be active on another pathway that is mainly followed by the virus [82] [85] [87] [90]. Some now suggest against Covid-19 to explore azithromycin / ambroxol dual therapy [91].

Outpatient treatments are no longer lacking: Ivermectin, vitamin C, quercetin, vitamin D 3, B vitamins, zinc, melatonin and aspirin for Dr. Marik of Eastern Virginia Medical School for example [92] [93]. line on nitazoxanide [94] or famotidine [95] also appear. In Volgograd, favipiravir, arbidol® and bromhexine are mentioned [96] …

Apparently this was written before Dr. Marik added ivermectin to his protocol.

permalink

The FLCCC is getting heavily censored by Facebook daily. It also looks like Twitter just censored me. They are asking me to verify code through a phone number I don't recognize. I'm not sure I'll be able to use that account again.

permalink

Imagine training to be a GP or a specialist for nearly a decade, concentrating on developing ethical professional judgement all these years, practising maybe for a few more decades with your patients and being banned from exercising your professional judgement in the middle of a pandemic while you are trying to help and save your patients.

I expect we will see an increase in suicides among physicians.

This is a great article, what the media really should be doing, asking questions, presenting the variety of treatment options that are proposed and reported around the world.

permalink